sp-3164
salarius pharma
['sp-3164', 'salarius']
salarius pharmaceuticals presents sp-3164 targeted protein degrader preclinical data at the european hematology association 2023 hybrid congress 
Salarius is a cancer-focused biotechnology company. Currently in clinical trials for Ewing Sarcoma w/ Orphan Drug & Rare Pediatric Disease Designation.